US not fully safe with vaccinations unless Covid variants curbed: USAID

The United States is not assured of being fully safe from the coronavirus even with its high rate in vaccination unless it extends the global fight to defeat the variants from the scourge

students, us, UNITED STATES, abroad, foreign, universities, indian
ANI US
2 min read Last Updated : May 25 2021 | 7:28 AM IST

The United States is not assured of being fully safe from the coronavirus even with its high rate in vaccination unless it extends the global fight to defeat the variants from the scourge, US Agency for International Development (USAID) COVID-19 Task Force Jeremy Konyndyk said Monday.

"We recognize that no matter how many people we vaccinated at home, the United States will not be fully safe as long as the virus rages on around the rest of the world and continues to replicate and generate new and potentially more dangerous," Konyndyk, who is assisting the Biden administration's global response to the coronavirus pandemic, said.

Konyndyk cited India as an example of the work that needed to be done in subduing mutations of the virus, with President Joe Biden pledging to Indian Prime Minister Narendra Modi last week a range of emergency assistance, including oxygen-related supplies, vaccine materials and therapeutics.

"[The] variants (and) current surge in South Asia really underscore the devastating consequences and risks of continued global transmission and the urgency of accelerating efforts to end the pandemic," Konyndyk said.

In a speech to Congress last month, Biden said the United States would become "an arsenal of vaccines" for other countries once vaccination targets for Americans were met. Biden said the United States would make 20 million additional vaccines available for other countries by the end of June from its reserves of Pfizer, Moderna and Johnson & Johnson shots.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineUnited States

First Published: May 25 2021 | 7:07 AM IST

Next Story